Endoscopy News and Research RSS Feed - Endoscopy News and Research

Pentax Medical announces new chief marketing officer and Americas region president

David Woods, the current president of PENTAX Medical of the Americas, has been appointed as the new global Chief Marketing Officer (CMO), effective April 1, 2015... [More]
Study shows how PDT for pancreatic cancer can be included in physician practice without significant cost

Study shows how PDT for pancreatic cancer can be included in physician practice without significant cost

Late stage pancreatic cancer benefits from photodynamic therapy (PDT) but the resources needed for the usual accompanying dosimetry present barriers, Dartmouth researchers Jonathan T. Elliott, PhD and Brian C. Pogue, PhD have mitigated by using common clinical technologies. [More]
Medigus announces completion of three MUSE procedures for GERD treatment in Italy

Medigus announces completion of three MUSE procedures for GERD treatment in Italy

Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced the completion of three MUSE procedures in Italy by renowned gastroenterologist, Professor Pier Alberto Testoni, Director of Gastroenterology and Digestive Endoscopy IRCCS at San Raffaele Hospital in Milan. [More]
Loyola's Neil Gupta recommends patients to ask four questions when planning a colonoscopy

Loyola's Neil Gupta recommends patients to ask four questions when planning a colonoscopy

"Most people focus on the dislike of the preparation, the need to arrange transportation and the fear of being anesthetized during the procedure and then potentially getting a cancer diagnosis," says Neil Gupta, MD, MPH, Director of Endoscopy at Loyola University Health System. "Screening colonoscopy is a very critical examination that really can determine life and death when it comes to colon cancer. It is now clear that not every colonoscopy is equal. Once you've decided it's time to get a screening colonoscopy, the next step is to make sure that you get a high-quality one." [More]
The Medical Minute highlights risk and symptoms of IBD in children

The Medical Minute highlights risk and symptoms of IBD in children

Occasional stomach aches are part of life. But when they continue for more than a few weeks, come back often or are accompanied by bloody stools and additional symptoms, the cause could be inflammatory bowel disease, or IBD. [More]
Norgine partners with Arc Medical to commercialize and distribute ENDOCUFF VISION

Norgine partners with Arc Medical to commercialize and distribute ENDOCUFF VISION

Norgine and Arc Medical Design Ltd. today announced a partnership that will see Norgine commercialising and distributing ENDOCUFF VISION, a Class 1 sterile medical device used in colonoscopy, across a number of major European markets, Australia and New Zealand. Norgine's first launch of ENDOCUFF VISION will take place in the UK Q2 2015. [More]
Regenstrief researchers create accurate system for tracking quality of colonoscopies

Regenstrief researchers create accurate system for tracking quality of colonoscopies

An accurate system for tracking the quality of colonoscopies and determining the appropriate intervals between these procedures could contribute to both better health outcomes and lower costs. Clinician-researchers from the Regenstrief Institute have created and tested such a system in the nation's first multiple institution colonoscopy quality measurement study utilizing natural language processing and report that it is as accurate but less expensive than human review. [More]
MedUni Vienna experts recommend regular colonoscopy screening to prevent bowel cancer

MedUni Vienna experts recommend regular colonoscopy screening to prevent bowel cancer

Bowel cancer is one of the most common types of cancer. The prognosis depends greatly on the stage at which the tumour is discovered. Colonoscopy is regarded as the best method for identifying pre-cancerous changes. If these changes are treated promptly, the disease can be stopped in its tracks. [More]
Prime Healthcare acquires two hospitals from subsidiaries of Community Health Systems

Prime Healthcare acquires two hospitals from subsidiaries of Community Health Systems

Prime Healthcare announced today that it has completed its acquisition of two hospitals from subsidiaries of Community Health Systems: Dallas Regional Medical Center in Mesquite, Texas and Riverview Regional Medical Center in Gadsden, Alabama, as well as related outpatient services. [More]

ChartSpan Medical Technologies raises $1.7 million in capital round

ChartSpan Medical Technologies announced it has successfully raised a capital round of $1.7 million dollars. Since becoming the most downloaded iPhone and iPad medical app in the U.S. in December, ChartSpan continues to disrupt healthcare with innovative technology empowering patients to manage their own healthcare records and information. [More]
RD Biomed to launch reflux diagnostic study in China

RD Biomed to launch reflux diagnostic study in China

RD Biomed, the Hull-based medical technology company, will launch a study with over 1,000 patients in China to measure the effectiveness of its reflux diagnostic device Peptest. [More]

GGEC opens new Endoscopy Center in Gastonia, NC

Four physicians, Sam Drake, MD; Bill Watkins, MD; Neville Forbes, MD; Austin Osemeka, MD and staff of the Greater Gaston Endoscopy Center (GGEC) joined by Physicians Endoscopy are pleased to announce the opening of their new Endoscopy Center in Gastonia, NC. [More]
New Endoscopic Technique

New Endoscopic Technique

A flexible wide-field endoscope utilising blue excitation light provides label-free contrast of tissue based on fluorescence lifetime imaging of tissue autofluorescence. [More]
RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device

RTI-HS, FDA partner to study patients' preferences that contributed to approval of new obesity device

RTI Health Solutions, a business unit of RTI International, partnered with the U.S. Food and Drug Administration to conduct a study on patients' preferences which contributed to the Agency's regulatory decision to approve the Maestro Rechargeable System, a first-of-kind device to treat obesity. [More]
Novel technique could help identify cancerous tissue during brain tumor surgery

Novel technique could help identify cancerous tissue during brain tumor surgery

A novel radioguided surgery technique could quickly and effectively identify residual cancer cells during brain tumor surgery, with low radiation exposure for both patients and surgeons. The study, featured in the January 2015 issue of the Journal of Nuclear Medicine, reports that Y-90 DOTATOC, a beta-minus-emitting tracer, can effectively delineate the margins of meningiomas and high-grade gliomas. [More]
Mayo Clinic study dispels myth that cancer biopsies cause cancer to spread

Mayo Clinic study dispels myth that cancer biopsies cause cancer to spread

A study of more than 2,000 patients by researchers at Mayo Clinic's campus in Jacksonville, Florida, has dispelled the myth that cancer biopsies cause cancer to spread. In the Jan. 9 online issue of Gut, they show that patients who received a biopsy had a better outcome and longer survival than patients who did not have a biopsy. [More]

Mayo Clinic researchers correctly evaluate polyps using high-definition optical lenses

It may not be necessary for experienced gastroenterologists to send polyps they remove from a patient's colon to a pathologist for examination, according to a large study conducted by physician researchers at the Jacksonville campus of Mayo Clinic. [More]
Olympus receives FDA clearance for Narrow Band Imaging

Olympus receives FDA clearance for Narrow Band Imaging

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today FDA 510(k) clearance of Narrow Band Imaging (NBI) as enabling effective targeting of biopsies not seen under white light and improved visualization of tumor boundaries in Non-Muscle-Invasive Bladder Cancer (NMIBC) patients. [More]
Ashish Nimgaonkar wins AGA-Boston Scientific Career Development Technology & Innovation Award

Ashish Nimgaonkar wins AGA-Boston Scientific Career Development Technology & Innovation Award

The American Gastroenterological Association Research Foundation is pleased to announce that Ashish Nimgaonkar, MBBS, MTech, MS, from John Hopkins University, has received the inaugural AGA-Boston Scientific Career Development Technology & Innovation Award. This award is graciously supported by a grant from Boston Scientific, a leading innovator of medical solutions. [More]
New light-triggered strategy can provide accurate control over aptamer-based therapeutics

New light-triggered strategy can provide accurate control over aptamer-based therapeutics

While aptamers—single-stranded nucleic acids—offer promise as drug-delivery tools for cancer treatment, it has proven difficult to get them to tumor cells at therapeutic levels. [More]
Advertisement
Advertisement